Literature DB >> 18559549

Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial.

Gerd Bobe1, Leah B Sansbury, Paul S Albert, Amanda J Cross, Lisa Kahle, Jason Ashby, Martha L Slattery, Bette Caan, Electra Paskett, Frank Iber, James Walter Kikendall, Peter Lance, Cassandra Daston, James R Marshall, Arthur Schatzkin, Elaine Lanza.   

Abstract

Two recent case-control studies suggested that some flavonoid subgroups may play a role in preventing colorectal cancer. Previous prospective cohort studies generally reported no association; however, only a small subset of flavonoids was evaluated and partial flavonoid databases were used. We used the newly constructed U.S. Department of Agriculture flavonoid database to examine the association between consumption of total flavonoids, 6 flavonoid subgroups, and 29 individual flavonoids with adenomatous polyp recurrence in the Polyp Prevention Trial. The Polyp Prevention Trial was a randomized dietary intervention trial, which examined the effectiveness of a low-fat, high-fiber, high-fruit, and high-vegetable diet on adenoma recurrence. Intakes of flavonoids were estimated from a food frequency questionnaire. Multivariate logistic regression models (adjusted for age, body mass index, sex, regular non-steroidal anti-inflammatory use, and dietary fiber intake) were used to estimate odds ratios and 95% confidence intervals for both any and advanced adenoma recurrence within quartiles of energy-adjusted flavonoid intake (baseline, during the trial, and change during the trial). Total flavonoid intake was not associated with any or advanced adenoma recurrence. However, high intake of flavonols, which are at greater concentrations in beans, onions, apples, and tea, was associated with decreased risk of advanced adenoma recurrence (4th versus 1st quartile during the trial; odds ratio, 0.24; 95% confidence interval, 0.11, 0.53; P(trend) = 0.0006). Similar inverse associations were observed to a smaller extent for isoflavonoids, the flavonol kaempferol, and the isoflavonoids genistein and formononetin. Our data suggest that a flavonol-rich diet may decrease the risk of advanced adenoma recurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559549      PMCID: PMC2517243          DOI: 10.1158/1055-9965.EPI-07-0747

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

1.  Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.

Authors:  M J Wargovich; A Jimenez; K McKee; V E Steele; M Velasco; J Woods; R Price; K Gray; G J Kelloff
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

2.  Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells.

Authors:  Daisuke Ichimatsu; Masaaki Nomura; Seiji Nakamura; Shuzo Moritani; Koichi Yokogawa; Shinjiro Kobayashi; Tatsuo Nishioka; Ken-ichi Miyamoto
Journal:  Mol Carcinog       Date:  2007-06       Impact factor: 4.784

3.  Distinctive antioxidant and antiinflammatory effects of flavonols.

Authors:  Lisu Wang; Yi-Chen Tu; Tzi-Wei Lian; Jing-Ting Hung; Jui-Hung Yen; Ming-Jiuan Wu
Journal:  J Agric Food Chem       Date:  2006-12-27       Impact factor: 5.279

4.  The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics.

Authors:  E Lanza; A Schatzkin; R Ballard-Barbash; D Corle; C Clifford; E Paskett; D Hayes; E Bote; B Caan; M Shike; J Weissfeld; M Slattery; D Mateski; C Daston; D C Clifford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-05       Impact factor: 4.254

5.  Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro.

Authors:  S J Duthie; V L Dobson
Journal:  Eur J Nutr       Date:  1999-02       Impact factor: 5.614

6.  Dietary flavonoids and the risk of lung cancer and other malignant neoplasms.

Authors:  P Knekt; R Järvinen; R Seppänen; M Hellövaara; L Teppo; E Pukkala; A Aromaa
Journal:  Am J Epidemiol       Date:  1997-08-01       Impact factor: 4.897

7.  Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships.

Authors:  Ching-Chow Chen; Man-Ping Chow; Wei-Chien Huang; Yi-Chu Lin; Ya-Jen Chang
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

8.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.

Authors:  M G Hertog; P C Hollman; M B Katan; D Kromhout
Journal:  Nutr Cancer       Date:  1993       Impact factor: 2.900

9.  Modulation by flavonoids of the effects of a food mutagen in different thalassaemia genotypes in the Comet assay.

Authors:  Afruj Ali Ruf; John Webb; Diana Anderson
Journal:  Teratog Carcinog Mutagen       Date:  2003

10.  Molecular Mechanisms Behind the Chemopreventive Effects of Anthocyanidins.

Authors:  De-Xing Hou; Makoto Fujii; Norihiko Terahara; Makoto Yoshimoto
Journal:  J Biomed Biotechnol       Date:  2004
View more
  35 in total

1.  Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Connie J Rogers; Kenneth W Hance; Paul S Albert; Adeyinka O Laiyemo; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.

Authors:  Liang Zheng; Lijun Zhu; Min Zhao; Jian Shi; Yuhuan Li; Jia Yu; Huangyu Jiang; Jinjun Wu; Yunli Tong; Yuting Liu; Ming Hu; Linlin Lu; Zhongqiu Liu
Journal:  AAPS J       Date:  2016-07-08       Impact factor: 4.009

Review 3.  Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Treat Rev       Date:  2009-08-05       Impact factor: 12.111

4.  Association of dietary quercetin with reduced risk of proximal colon cancer.

Authors:  Zora Djuric; Richard K Severson; Ikuko Kato
Journal:  Nutr Cancer       Date:  2012-03-19       Impact factor: 2.900

5.  Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial.

Authors:  Gerd Bobe; Paul S Albert; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Nancy H Colburn; Amanda J Cross
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-18

Review 6.  Considering the value of dietary assessment data in informing nutrition-related health policy.

Authors:  James R Hébert; Thomas G Hurley; Susan E Steck; Donald R Miller; Fred K Tabung; Karen E Peterson; Lawrence H Kushi; Edward A Frongillo
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

7.  Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

8.  Identification and monitoring of metabolite markers of dry bean consumption in parallel human and mouse studies.

Authors:  Thushanthi Perera; Matthew R Young; Zhiying Zhang; Gwen Murphy; Nancy H Colburn; Elaine Lanza; Terryl J Hartman; Amanda J Cross; Gerd Bobe
Journal:  Mol Nutr Food Res       Date:  2015-02-23       Impact factor: 5.914

9.  Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  G Bobe; G Murphy; P S Albert; L B Sansbury; E Lanza; A Schatzkin; N H Colburn; A J Cross
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

Review 10.  Inhibition of cancer cell invasion and metastasis by genistein.

Authors:  Janet M Pavese; Rebecca L Farmer; Raymond C Bergan
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.